TrialInternational journal of urology : official journal of the Japanese Urological Association2020

Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients.

Yoshihiko Tomita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.